First, we quantified SHANK3 in the detergent-soluble protein fractions from the parietal cortex of individuals with a neuropathological diagnosis of AD (Braak Stages 4 and 5), compared with controls (Braak Stages 1-3). This evidence concerns the gene SHANK3 and Alzheimer disease.